Bacterial, Archaea, and Viral Transcripts (BAVT) Expression in Gynecological Cancers and Correlation with Regulatory Regions of the Genome

por Gonzalez-Bosquet, Jesus, Pedra-Nobre, Silvana, Devor, Eric J., Thiel, Kristina W., Goodheart, Michael J., Bender, David P., Leslie, Kimberly K.
Publicado no Cancers (Basel) (2021)

A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecolog...

por Coleman, Robert L., Sill, Michael W., Thaker, Premal H., Bender, David P., Street, Daron, McGuire, William, Johnston, Carolyn M., Rotmensch, Jacob
Publicado no Gynecol Oncol (2015)

Interval debulking surgery is not worth the wait: a National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy

por Lyons, Yasmin A, Reyes, Henry D, McDonald, Megan E, Newtson, Andreea, Devor, Eric, Bender, David P, Goodheart, Michael J, Gonzalez Bosquet, Jesus
Publicado no Int J Gynecol Cancer (2020)

A Phase II Trial of Intraperitoneal EGEN-001, An IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallo...

por Alvarez, Ronald D., Sill, Michael W., Davidson, Susan A., Muller, Carolyn Y., Bender, David P., DeBernardo, Robert L., Behbakht, Kian, Huh, Warner K.
Publicado em 2014

A phase I–II evaluation of veliparib (NSC#737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: An NRG On...

por Kunos, Charles, Deng, Wei, Dawson, Dawn, Lea, Jayanthi S., Zanotti, Kristine M., Gray, Heidi J., Bender, David P., Guaglianone, Perry P., Carter, Jori S., Moore, Kathleen N.
Publicado no Int J Gynecol Cancer (2015)

A Randomized Phase II Study of Cabozantinib Versus Weekly Paclitaxel in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer: an...

por Matulonis, Ursula A., Sill, Michael W., Makker, Vicky, Mutch, David G., Carlson, Jay W., Darus, Christopher J., Mannel, Robert S., Bender, David P., Crane, Erin K., Aghajanian, Carol
Publicado no Gynecol Oncol (2018)

Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer

por McDonald, Megan E., Salinas, Erin A., Devor, Eric J., Newtson, Andreea M., Thiel, Kristina W., Goodheart, Michael J., Bender, David P., Smith, Brian J., Leslie, Kimberly K., Gonzalez-Bosquet, Jesus
Publicado no Int J Mol Sci (2019)

Creation and validation of models to predict response to primary treatment in serous ovarian cancer

por Gonzalez Bosquet, Jesus, Devor, Eric J., Newtson, Andreea M., Smith, Brian J., Bender, David P., Goodheart, Michael J., McDonald, Megan E., Braun, Terry A., Thiel, Kristina W., Leslie, Kimberly K.
Publicado no Sci Rep (2021)

Life Stress as a Risk Factor for Sustained Anxiety and Cortisol Dysregulation During the First Year of Survivorship in Ovarian Cancer

por Armer, Jessica S., Clevenger, Lauren, Davis, Lauren Z., Cuneo, Michaela, Thaker, Premal H., Goodheart, Michael J., Bender, David P., Dahmoush, Laila, Sood, Anil K., Cole, Steven W., Slavich, George M., Lutgendorf, Susan K.
Publicado no Cancer (2018)

An integrated prediction model of recurrence in endometrial endometrioid cancers

por Miller, Marina D, Salinas, Erin A, Newtson, Andreea M, Sharma, Deepti, Keeney, Matthew E, Warrier, Akshaya, Smith, Brian J, Bender, David P, Goodheart, Michael J, Thiel, Kristina W, Devor, Eric J, Leslie, Kimberly K, Gonzalez-Bosquet, Jesus
Publicado no Cancer Manag Res (2019)

A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables

por Salinas, Erin A., Miller, Marina D., Newtson, Andreea M., Sharma, Deepti, McDonald, Megan E., Keeney, Matthew E., Smith, Brian J., Bender, David P., Goodheart, Michael J., Thiel, Kristina W., Devor, Eric J., Leslie, Kimberly K., Gonzalez Bosquet, Jesus
Publicado no Int J Mol Sci (2019)

A Phase II Study of Frontline Paclitaxel/Carboplatin/Bevacizumab, Paclitaxel/Carboplatin/Temsirolimus, or Ixabepilone/Carboplatin/Bevacizumab in Advanced/Recurrent Endometrial Canc...

por Aghajanian, Carol, Filiaci, Virginia, Dizon, Don S., Carlson, Jay W., Powell, Matthew A., Alvarez Secord, Angeles, Tewari, Krishnansu S., Bender, David P., O’Malley, David M., Stuckey, Ashley, Gao, JianJiong, Dao, Fanny, Soslow, Robert A., Lankes, Heather A., Moore, Kathleen, Levine, Douglas A.
Publicado no Gynecol Oncol (2018)

Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma

por Rose, Peter G, Java, James J, Salani, Ritu, Geller, Melissa A, Alvarez, Angeles, Tewari, Krishnansu S, Bender, David P, Mutch, David G, Friedlander, Michael L, Van Le, Linda, Method, Michael W, Hamilton, Chad A, Lee, Roger B, Wenham, Robert M, Guntupalli, Saketh R, Markman, Maurie, Muggia, Franco M, Armstrong, Deborah K, Bookman, Michael A, Burger, Robert A, Copeland, Larry J
Publicado no Obstet Gynecol (2019)